Eli Lilly and Company CEDEAR Logo

Eli Lilly and Company CEDEAR (LLY)

BCBA

Currency in ARS
34,220.00
+880.00 (+2.64%)

Closed

Oct 7, 2026

Day's Range

33,940.00
34,680.00

52 wk Range

19,640.00
36,520.00

Analyst Ratings - LLY - Eli Lilly and Company CEDEAR

Analyst ratings

DateFirmActionRating
Apr 03, 2024Erste GroupUpgradeHold → Buy
Nov 08, 2023JP MorganReiteratesOverweight
Aug 10, 2023Goldman SachsMaintainsNeutral
Aug 09, 2023BarclaysMaintainsOverweight
Aug 09, 2023BMO CapitalMaintainsOutperform
Aug 09, 2023Cantor FitzgeraldReiteratesOverweight
Aug 09, 2023Credit SuisseMaintainsOutperform
Aug 09, 2023Goldman SachsMaintainsNeutral
Aug 09, 2023JefferiesUpgradeHold → Buy
Aug 09, 2023JP MorganMaintainsOverweight
Items per row:

Estimates - LLY - Eli Lilly and Company CEDEAR

Estimate momentum

Current quarter · How the consensus estimate has moved over the last 90 days.

Revised last month0/0

EPS estimates

PeriodAnalystsLowAverageHighYear ago
Current quarter-----
Next quarter-----
Current year-----
Next year-----

Earnings History - LLY - Eli Lilly and Company CEDEAR

Estimate surprises

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-04-28Pre Market----
2026-02-03Pre Market----
2025-12-03After Hours0.270.45+0.18‪+66.67%‬

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.